Robert J. Gould
2018 - Fulcrum Therapeutics
In 2018, Robert J. Gould earned a total compensation of $853.6K as President and Chief Executive Officer at Fulcrum Therapeutics.
Compensation breakdown
Bonus | $203,734 |
---|---|
Salary | $442,900 |
Stock Awards | $207,000 |
Total | $853,634 |
Gould received $442.9K in salary, accounting for 52% of the total pay in 2018.
Gould also received $203.7K in bonus and $207K in stock awards.
Rankings
In 2018, Robert J. Gould's compensation ranked 9,916th out of 14,244 executives tracked by ExecPay. In other words, Gould earned more than 30.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,916 out of 14,244 | 30th |
Division Manufacturing | 4,005 out of 5,765 | 31st |
Major group Chemicals And Allied Products | 1,505 out of 2,128 | 29th |
Industry group Drugs | 1,270 out of 1,817 | 30th |
Industry Pharmaceutical Preparations | 977 out of 1,391 | 30th |
Source: SEC filing on April 29, 2020.
Gould's colleagues
We found one more compensation record of an executive who worked with Robert J. Gould at Fulcrum Therapeutics in 2018.
2018
Bryan Stuart
Fulcrum Therapeutics